Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Cancer Research Stories

2013-09-04 16:27:36

At St. Jude, doctors and scientists work to improve childhood cancer survival rates as well as enhance patients' long-term quality of life after treatment MEMPHIS, Tenn., Sept. 4, 2013 /PRNewswire-USNewswire/ -- Despite a steady rise in survival rates, childhood cancer remains the leading cause of death by disease among young Americans. St. Jude Children's Research Hospital doctors and scientists are working to change that statistic. September marks Childhood Cancer Awareness...

2013-09-04 12:33:03

Sharing online video will provide the opportunity to fund 1,000 hours of research MILWAUKEE, Sept. 4, 2013 /PRNewswire/ -- Today's superheroes don't drive a Batmobile or fly through the air faster than the speed of light. Their capes are white lab coats and their superpower is the ability to cure. They are men and women researching cures for childhood cancer - the leading cause of death by disease in children under the age of 15 in the U.S.[1]- which is vastly underfunded[2]. To...

2013-09-01 23:02:18

The National Foundation for Cancer Research (NFCR) announced their partnership with yoga and Pilates studios across the country for a nationwide cancer prevention and education campaign entitled “Stretch to the Cure.” Bethesda, MD (PRWEB) September 01, 2013 The National Foundation for Cancer Research (NFCR) announced their partnership with yoga and Pilates studios across the country for a nationwide cancer prevention and education campaign, entitled “Stretch to the Cure.”...

2013-08-30 23:28:10

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a new discovery of an immunotherapy target in aggressive brain tumors. New York, NY (PRWEB) August 30, 2013 Voices Against Brain Cancer discusses the discovery of a new immunotherapy target in aggressive brain tumors that could help patients who do not respond to current chemotherapy. According to an August 28, 2013 Med City News article titled “Researchers find new immunotherapy...

2013-08-30 12:49:41

Collagen, the stuff of ligaments and skin, and the most abundant protein in the human body, has an extraordinary role in triggering chemical signals that help protect the body from cancer, a new study reveals. Scientists at The Institute of Cancer Research, London, have uncovered a series of chemical signals sent out by collagen that appear to protect against cancer's growth. Boosting those signals could act as an effective treatment for cancers that grow in the presence of collagen,...

2013-08-29 20:21:26

By the National Cancer Institute BETHESDA, Md., Aug. 29, 2013 /PRNewswire-USNewswire/ -- Somewhere in a research laboratory, an African American woman with a medical degree is helping to solve the mysteries of breast cancer. She is working with colleagues to find out why young African American women are disproportionately affected by triple-negative breast cancer, an aggressive and often deadly form of the disease. In another laboratory, an African American man who is an expert on...

2013-08-28 23:20:09

The Chris Elliott Fund Presents the 2nd Annual Brains Matter Patient and Caregiver Awareness-Day Conference on September 27th 2013 Seattle, WA (PRWEB) August 28, 2013 The Chris Elliott Fund announces the second annual Brains Matter Conference, on Friday, September 27th from 8am to 6pm at the Bellevue Club in Bellevue, WA. This conference is available for patients and caregivers affected by brain cancer being offered free of charge. This event directly benefits the community of brain...

2013-08-27 12:28:22

Philanthropic money supporting cancer immunotherapy research around the world NEW YORK, Aug. 27, 2013 /PRNewswire/ -- The Cancer Research Institute (CRI), a New York-based nonprofit organization committed to developing immune system-based cancer treatments, awarded more than $14.6 million in grants and fellowships in the 2013 fiscal year ending June 30, 2013. That funding supports pioneering clinical and laboratory research on cancer immunotherapy. Cancer immunotherapy is a new class of...

2013-08-27 12:28:14

CINCINNATI, Aug. 27, 2013 /PRNewswire-USNewswire/ -- New research in the Journal of Clinical Investigation suggests that blocking a protein normally credited with suppressing leukemia may be a promising therapeutic strategy for an aggressive form of the disease called acute myeloid leukemia (AML). (Logo: http://photos.prnewswire.com/prnh/20110406/MM79025LOGO) Researchers from Cincinnati Children's Hospital Medical Center report their results in a study posted online Aug. 27 by the...

2013-08-27 08:27:31

Company Prepares for Pivotal Phase 3 Study of Entinostat, Most Advanced HDAC Inhibitor in Development for ER+ Metastatic Breast Cancer WALTHAM, Mass., Aug. 27, 2013 /PRNewswire/ -- Syndax Pharmaceuticals Inc., which is developing epigenetic therapies for treatment-resistant cancers, today announced it has secured a $26.6 million Series B financing. Participating investors included Domain Associates, MPM Capital, Forward Ventures and RusnanoMedInvest (RMI). Syndax plans to use the...